Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
3R01CA042522-05S1
Application #
3183966
Study Section
Experimental Therapeutics Subcommittee 1 (ET)
Project Start
1987-04-01
Project End
1993-11-30
Budget Start
1991-12-01
Budget End
1992-11-30
Support Year
5
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Barbara Ann Karmanos Cancer Institute
Department
Type
DUNS #
City
Detroit
State
MI
Country
United States
Zip Code
48201
Gill, R; Wang, H; Bluethmann, H et al. (1994) Activation of natural killer cells by mouse mammary tumor virus C4 in BALB/c and T-cell receptor V beta 2-transgenic mice. Cancer Res 54:1529-35
Wang, H; Gill, R F; Lichlyter, D et al. (1994) Deletion of CD4+ T cells and thymocytes by apoptosis in mouse mammary tumor virus (C4)-infected V beta 2 transgenic mice. Eur J Immunol 24:2950-6
Shakhov, A N; Wang, H; Acha-Orbea, H et al. (1993) A new infectious mammary tumor virus in the milk of mice implanted with C4 hyperplastic alveolar nodules. Eur J Immunol 23:2765-9
Wei, W Z; Gill, R F; Wang, H (1993) Mouse mammary tumor virus associated antigens and superantigens--immuno-molecular correlates of neoplastic progression. Semin Cancer Biol 4:205-13
Wei, W Z; Wang, H; Ficsor-Jacobs, R et al. (1992) Adoptive transfer of V beta 2-deleting activity with host cells from mice implanted with C4 preneoplastic hyperplastic alveolar nodules. Cancer Res 52:5183-9
Wei, W Z; Ficsor-Jacobs, R; Tsai, S J et al. (1991) Elimination of V beta 2 bearing T-cells in BALB/c mice implanted with syngeneic preneoplastic and neoplastic mammary lesions. Cancer Res 51:3331-3
Maloney, T; Wei, W Z (1990) Two-dimensional gel analysis of polypeptides from normal, preneoplastic and neoplastic mouse mammary tissues. Cancer Immunol Immunother 30:367-73
Wei, W Z; Fisher, S; Kohler, H (1989) Improved anti-tumor reactivity with monoclonal anti-idiotypic antibody conjugated to syngeneic mouse red blood cells. J Immunol Methods 122:227-34
Wei, W Z; Ratner, S (1987) A new assay to measure monoclonal antibody-dependent complement or macrophage-mediated tumor growth inhibition. J Immunol Methods 102:53-8